pierre van damme
Head of the Centre for the Evaluation of Vaccination @ Vaccinopolis, University of Antwerp
University of Antwerp
WIlrijk, Belgium
About me
Prof. Dr. Pierre Van Damme obtained his PhD in epidemiology and public health in 1994. He was for more than 35 years active in vaccine trial and infectious disease research. Since 2000 he is full professor in Vaccinology at the University of Antwerp, Faculty of Medicine and Health Sciences, and teaches vaccinology in national and international courses. Pierre Van Damme is heading the Centre for the Evaluation of Vaccination (CEV, University of Antwerp), which he founded in 1994, and director of Vaccinopolis, a unique facility in Europe for vaccine trials and human challenge studies. With Arnaud Marchant he set up the recently founded European Plotkin Institute for Vaccinology, an initiative to accelerate the evaluation of vaccines for pandemic and endemic pathogens. The CEV is a WHO Collaborating Centre for the WHO European Region for the control and prevention of infectious diseases. Pierre Van Damme has been for more than 25 years a regular advisor for national and international organizations. Pierre Van Damme obtained several awards, a.o. the Bill Marshall award of the ESPID society (2014) and the Paul Harris Fellowship by the Rotary Foundation (2017). He is a member of the Belgian Royal Academy of Medicine since 2008.
My organisation
We are the University of Antwerp, a leading academic institution in Belgium. Our diverse community of students, researchers, and professors collaborates to create innovative solutions and drive progress in various fields. With a strong focus on academic excellence and international partnerships, we aim to make a positive impact on society and shape the leaders of tomorrow. Join us at our campus in Antwerp and be part of our dynamic academic environment.
Additional questions
How would you categorise yourself?
Organisation Type
Areas of expertise
Therapeutic areas
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agreeSpeaker sessions (2)
Wednesday, 16 October 2024
16:00 - 17:30
Workshop 2: Impact of the European Clinical Trial Regulation
Thursday, 17 October 2024
16:00 - 16:40